Core Viewpoint - Revolut is reportedly in talks to acquire a major Asian bank as part of its expansion strategy in the region, with speculation around potential targets including DBS and various challenger banks [2][3]. Group 1: Potential Acquisition Targets - DBS Bank, headquartered in Singapore, operates in 19 markets across Asia and has a market valuation exceeding SGD$160 billion (USD$125 billion), making it an unlikely target for Revolut due to its size [3]. - Other potential targets include major challenger banks in Asia such as WeBank, MYbank, Kakaobank, Rakuten Bank, Sony Bank, Jibun Bank, PayPay Bank, BigPay, and Timo [4]. - GXS Bank in Singapore is identified as a likely target due to its digital-first approach and alignment with Revolut's business model, despite being loss-making with revenues of only USD$22 million in 2024 [9][10]. Group 2: Market Context and Challenges - Many banks in Asia are facing challenges in growth due to property sector debt crises, slowing economic growth, and rising non-performing loans, particularly in China and Southeast Asia [5]. - The Chinese banking sector is struggling with high volumes of bad loans, making it a complex environment for any potential acquisition by Revolut [6]. - Regulatory hurdles in acquiring a bank in China are anticipated to be significant, potentially complicating Revolut's global expansion strategy [7]. Group 3: Strategic Considerations - ANZ's intention to sell its stake in Panin Bank is driven by a strategic shift to focus on its core domestic market and simplify its business, which may not align with Revolut's objectives [8]. - Acquiring GXS Bank could provide Revolut with a banking license in Singapore, which is crucial for expanding its service offerings beyond its current Major Payment Institution license [10][11]. - GXS Bank's existing digital banking license in Malaysia and operations through Superbank in Indonesia could facilitate Revolut's entry into other Asian markets, although further licensing would still be required [11].

Core Viewpoint - XBP Global is conducting its Fourth Quarter and Full Year 2025 Earnings Call, highlighting its financial performance and future outlook [2]. Group 1: Financial Performance - The earnings call is led by key executives including CEO Andrej Jonovic and CFO Dejan Avramovic, indicating a structured approach to discussing financial results [2]. - The company will reference pro forma and non-GAAP financial measures during the call, with reconciliations provided in the earnings release and investor presentation [5]. Group 2: Forward-Looking Statements - The remarks during the call may include forward-looking statements regarding future performance, outlook, and strategy, which are based on current expectations and assumptions [3]. - There are inherent risks and uncertainties associated with these forward-looking statements that could lead to actual results differing materially from those described [3].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased REGENXBIO, Inc. securities between February 9, 2022, and January 27, 2026, of the April 14, 2026, deadline to become lead plaintiffs in a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought REGENXBIO securities during the specified period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court by April 14, 2026, to serve as lead plaintiff [2]. - The lead plaintiff acts on behalf of other class members in directing the litigation [2]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm specializes in securities class actions and has a strong track record, including the largest securities class action settlement against a Chinese company [3]. - The firm was ranked No. 1 by ISS Securities Class Action Services for the number of securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions for investors [3]. - In 2019, the firm secured over $438 million for investors, and its founding partner was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020 [3]. Group 3: Case Specifics - The lawsuit alleges that defendants provided misleading information regarding REGENXBIO's RGX-111 gene therapy for treating severe Mucopolysaccharidosis Type I, while concealing material adverse facts about its efficacy and safety [4]. - Defendants made positive assertions about RGX-111's trial success based on favorable biomarker and safety data, which were later contradicted by the true details that emerged, leading to investor damages [4].

Group 1 - SpaceX is preparing for a significant initial public offering (IPO) internally codenamed Project Apex, expected to take place in June and valued at approximately $1.75 trillion [2][5] - The IPO will involve a large syndicate of at least 21 banks, one of the largest in recent years, indicating the scale and complexity of the offering [3][4] - Major banks serving as active bookrunners include Morgan Stanley, Goldman Sachs, JPMorgan Chase, Bank of America, and Citigroup, with an additional 16 banks participating in smaller roles [3][4] Group 2 - The banks involved will cater to various investor channels, including institutional, high-net-worth, and retail investors, across different geographic regions [4] - The structure of large IPO syndicates has become more common for mega deals, as seen in previous high-profile listings like ARM Holdings and Alibaba Group [5][6] - The plan for the IPO is still subject to change, and more banks may be added to the syndicate as the process evolves [5]

Core Viewpoint - Micron Technology is experiencing significant growth due to a shortage of high-performance memory for data centers, with strong financial performance expected in the coming years as demand continues to exceed supply [1][7]. Group 1: Financial Performance - In the recent quarter, Micron's revenue tripled year over year to nearly $24 billion, with earnings per share increasing from $1.41 to $12.07 [5]. - Analysts project earnings to rise to $58 per share in fiscal 2026, $98 in fiscal 2027, and then decrease to $77 in fiscal 2028, indicating potential cyclical pricing issues as supply catches up [11]. Group 2: Demand Drivers - The demand for advanced memory is being driven by AI computing systems, particularly GPUs, which require substantial memory to process large data volumes, with current production only meeting half to two-thirds of customer demand [6]. - Demand is also expanding beyond data centers, with consumer devices like smartphones and humanoid robots expected to increase memory requirements significantly [8]. Group 3: Market Outlook - Management anticipates that the memory supply shortage will persist through the end of 2026, supporting higher earnings in the near term [7]. - Despite the current tight supply, there are concerns that increased capacity could lead to oversupply and lower memory prices in the future, reflecting the cyclical nature of the industry [10][13].

Core Viewpoint - A class action has been filed against Lufax Holding Ltd. for alleged inadequate internal controls and material misstatements in financial reports during the class period from April 7, 2023, to January 26, 2025 [1][2]. Group 1: Allegations and Financial Impact - The allegations include that Lufax made material misstatements in its financial reports and lacked adequate internal controls [2]. - On January 27, 2025, Lufax announced the removal of its auditor, PricewaterhouseCoopers (PwC), due to significant concerns regarding Lufax's financial disclosures, particularly the 2022 and 2023 Annual Reports [3]. - Following the announcement, Lufax's American Depositary Shares (ADSs) fell by $0.40, or 13.8%, closing at $2.49 on January 27, 2025. The next day, the ADSs dropped an additional $0.17, or 6.82%, to close at $2.32, and on January 29, they fell by $0.06, or 2.58%, to close at $2.26 [3]. Group 2: Shareholder Actions - Shareholders may be eligible to participate in the class action against Lufax and must submit their papers to the court by May 20, 2026, if they wish to serve as lead plaintiff [4]. - Shareholders do not need to participate in the case to be eligible for recovery and can remain absent class members if they choose [4]. Group 3: Legal Representation - All representation in the class action is on a contingency fee basis, meaning shareholders pay no fees or expenses [5]. - Robbins LLP is noted as a leader in shareholder rights litigation, focusing on helping shareholders recover losses and improve corporate governance [5].

HOUSTON, March 31, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (NASDAQ: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced the pricing of a best efforts public offering of an aggregate of 2,272,728 shares of its common stock (or common stock equivalents in lieu thereof) and warrants t ...

Core Viewpoint - A class action lawsuit has been filed against Aldeyra Therapeutics on behalf of investors who acquired its securities during the specified class period from November 3, 2023, to March 16, 2026 [1] Summary by Relevant Sections - **Company Information** - Aldeyra Therapeutics is identified as a publicly traded company on NASDAQ under the ticker symbol ALDX [1] - **Legal Proceedings** - The lawsuit is initiated by the law firm Kirby McInerney LLP, targeting investors who suffered losses on their Aldeyra investments during the class period [1] - Investors have until May 29, 2026, to request lead plaintiff appointment, indicating a timeline for potential claimants [1]

Core Viewpoint - First Northern Community Bancorp has announced a stock repurchase program aimed at enhancing shareholder value and maintaining a strong capital position [1][5]. Stock Repurchase Program - The program will commence on May 1, 2026, and will remain effective until April 30, 2028, unless terminated earlier [2]. - The company has authorized repurchases of up to 6% of its outstanding shares, which amounts to 984,579 shares based on the total of 16,409,660 shares as of March 26, 2026 [3]. - If all eligible shares are repurchased at the closing price of $15.85 per share, the total consideration would be approximately $15.6 million [3]. Capital Management - The Board of Directors has confirmed that the maximum aggregate repurchase amount will not impair the company's capital [4]. - The repurchase program is designed to be compliant with SEC regulations, specifically Rule 10b-18 [4]. Management's Perspective - The President and CEO, Jeremiah Smith, emphasized that the program reflects a commitment to disciplined capital management and aims to maximize long-term shareholder value [5]. - The program is expected to enhance returns for existing shareholders and improve market liquidity for the company's common shares [5]. Company Overview - First Northern Bank, the parent company of First Northern Community Bancorp, is an independent community bank established in 1910, serving multiple counties in California [6]. - The bank specializes in relationship banking and offers various lending services, including small business and mortgage loans [6].

Core Insights - The article discusses the impact of Federal Reserve communications on market-based inflation expectations, highlighting the significance of monetary policy surprises during FOMC meetings and press conferences [4][31]. Group 1: Monetary Policy Communication - Central banks primarily use short-term interest rate changes as their monetary policy tool, but effective transmission also relies on influencing broader financial conditions, including long-term rates and market prices [2]. - The Federal Reserve's communication methods, particularly post-FOMC meeting statements and press conferences, are crucial for assessing the effectiveness of its monetary policy [3][31]. - The SF Fed's US Monetary Policy Event-Study Database (USMPD) provides high-frequency changes in interest rates and asset prices around FOMC events, aiding in the analysis of monetary policy effects [6][7]. Group 2: Market Reactions to Policy Surprises - High-frequency monetary policy surprises are measured by changes in interest rates for short-maturity financial instruments around policy announcements, capturing new information about the Fed's policy path [5]. - The analysis shows that hawkish surprises lower market-based inflation expectations, while dovish surprises raise them, consistent with conventional monetary transmission [23][31]. - The largest market reactions to FOMC surprises occur at longer horizons, indicating a significant expected delay in the transmission of policy changes to inflation [24]. Group 3: Breakeven Inflation Rates - Breakeven inflation (BEI) rates, calculated as the difference between nominal and real Treasury yields, are used to measure market-based inflation expectations [13]. - Recent trends in BEI rates indicate fluctuations in inflation expectations, with the five-year BEI rate showing a range between 2.4% and 2.6% during periods of rising inflation concerns [17]. Group 4: Effects of FOMC Communications - The analysis of market reactions to FOMC communications reveals that both statements and press conferences lead to meaningful unexpected changes in the policy path [31]. - Press conference surprises have a stronger effect on inflation expectations compared to statement surprises, with a maximum impact of -0.6, indicating a significant decline in market expectations for inflation [29][30]. - The findings suggest that the Chair's remarks during press conferences serve as a powerful channel for communicating monetary policy, influencing market perceptions and expectations [30][31].